Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B244 intranasal spray in seasonal allergic rhinitis
NCT03290248Phase 2Completed
- Sponsor
- AOBiome
- Start
- Sep 2017
- Primary completion
- Dec 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 2
01
Overview
A Phase 2 trial of B244 in seasonal allergic rhinitis (SAR), sponsored by AOBiome. Started Sep 2017; status: completed.
02
Drugs
B244
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT03290248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290248.